Skip to main content
assistive.skiplink.to.breadcrumbs
assistive.skiplink.to.header.menu
assistive.skiplink.to.action.menu
assistive.skiplink.to.quick.search
Log in
Skip to sidebar
Skip to main content
Linked Applications
Loading...
Spaces
Collections
Hit enter to search
Help
Online Help
Keyboard Shortcuts
Feed Builder
What’s new
Available Gadgets
About Confluence
Log in
User Support Reference Group
Pages
Blog
Page tree
Browse pages
Configure
Space tools
Remove Read Confirmation
A
t
tachments (0)
Scaffolding History
Page History
Resolved comments
Page Information
View in Hierarchy
View Source
View Scaffolding XML
Export to PDF
Export to Word
Export to PDF
Hide Inline Comments
Copy with Scaffolding XML
Pages
…
SNOMED CT User Support Reference Group
Discussion Forum
DEUSG discussions
Jira links
Workflow
Viewtracker
Read Confirmation
Languages
Strength Representation in Drug Model
Created by
Shane Byrnes
, last modified on
2025-Mar-17
Shane Byrnes
Owner
66
View
0
Comment
New
Comments enabled
In the category:
DEUSG
Hi All,
As a follow up to our DEUSG meeting last week please use this discussion thread for any feedback on an different strength representations being used in the drug model.
Presentation is attached to bottom of meeting notes here:
https://confluence.ihtsdotools.org/display/USRG/2025-03-13%3A+Virtual
Thanks to Australia for the feedback and presentation.
Regards,
Shane
Contributors (0)
discussion-blueprint
discussion-deusg
Overview
Content Tools
Apps
{"serverDuration": 183, "requestCorrelationId": "95db3bff25256afb"}